Patent applications published 22 September 2010

Published: 14-Oct-2010
Patient Experience

Selected patent applications from the weekly European Patents Bulletin


  • Methods of synthesis and use of chemospheres
    The Johns Hopkins University 2229147*

  • Organic compounds
    Novartis 2229148*

  • Process for recovering flunixin from pharmaceutical compsns
    Intervet International 2229149*

  • Systems and methods for delivery of materials
    Landec Corp 2229150*

  • Salts of active ingredients with polymeric counter-ions
    BASF 2229151*

  • Water dispersible enteric coating formulation for nutraceutical and pharmaceutical dosage forms
    Hercules 2229152*

  • Coated extended release pharmaceutical compsns of levetiracetam
    Alembic 2229153*

  • Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitiser
    Grünenthal 2229154*

  • Particles in a capsule
    Northern Innovations and Formulations 2229155*

  • Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet
    Fertin Pharma 2229156*

  • Compressed chewing gum tablet
    Fertin Pharma 2229157*

  • Multi-zone films
    Novartis 2229159*

  • Leukaemic stem cell ablation
    ChemGenex 2229160*

  • Compsn comprising a nitrooxyderivative of acetaminophen and a anticonvulsant drug for the treatment of neuropathic pain
    Nicox 2229161*

  • Substituted benzoquinones and hydroquinones in the treatment of periodontal diseases
    Syntopic Group 2229162*

  • Antimicrobial compsns comprising fatty acids and milk proteins
    Westgate Biological 2229163*

  • Elevation of plasma HDL-cholesterol level
    Aarhus Universiteit 2229164*

  • Anti-glycation properties of asicatic acid and madecassic acid
    Bayer Consumer Care 2229165*


  • Combination between an isothiocyanate and levodopa for Parkinson’s disease treatment
    Alma Mater Studiorum-Universita’ di Bologna 2229166*

  • Mineralocorticoid receptor modulators
    Merck Sharp & Dohme 2229167*

  • Pharmaceutical compsn for treating malaria
    Mepha 2229168*

  • Preparation containing chromane-2-one derivatives
    Merck Patent 2229169*

  • Kinesin inhibitors as cancer therapeutics
    Novartis 2229170*

  • Methods and compsns for treating post-operative pain comprising a local anaesthetic
    Warsaw Orthopaedic, Medtronic 2229171*

  • Triazolo [4,5-D] pyrimidine compounds for treatment of abdominal aortic aneurysms
    AstraZeneca 2229172*

  • Oxazolidinones for the treatment and/or prophylaxis of heart failure
    Bayer Schering Pharma; Janssen Pharmaceutica 2229173*

  • Compsns comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders
    Novagali Pharma 2229174*

  • Compsn and method for dermal regeneration
    Ultraceuticals R&D 2229175*

  • Method of isolating non-senescent stem cells and uses thereof
    New York Medical College 2229177*

  • Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angio-genesis and the inflammatory pathways associated therewith
    Metaproteomics 2229178*

  • SLDLR in viral hepatitis
    Yeda Research & Development 2229179*

  • Compsns comprising superoxide dismutase and carboxy methyl beta-1,3-glucan
    DMG Italia 2229180*

  • Enhancement of immunogenicity of antigens
    Crossbeta Biosciences 2229181*

  • Polymeric drug carrier for image-guided delivery
    Koninkleijke Philips Electronics 2229182*

  • Use of particles comprising an alcohol
    Epitarget 2229183*

  • Anti-inflammatory compsns and combinations
    Cambridge Enterprise 2229184*

  • Co-administration of an agent linked to an internalisation peptide with an anti-inflammatory
    Nono; Arbor Vita Corp 2229185*

  • Carbohydrate conjugates as delivery agents for oligonucleotides
    Alnylam Pharmaceuticals 2229186*

  • Monoclonal antibody partner molecule conjugates directed to protein tyrosine kinase 7 (PTK7)
    Bristol-Myers Squibb 2229187*

  • Compsns and methods for treating cancers
    IRM 2229217*

  • Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree
    Newron Pharmaceuticals 2229351*

  • Carboxamide derivatives having cooling properties
    Givaudan 2229352*

  • Hydrocyanation of pentenenitriles
    Invista Technologies 2229353*

  • Process for making and refining 3-pentene-nitrile, and for refining 2-methyl-3-butene-nitrile
    Invista Technologies 2229354*

  • Method for preparing azetidine
    Sanofi-Aventis 2229355*

  • 1,2-disubstituted-4-benzylaminopyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidaemia or arteriosclerosis
    Novartis 2229356*

  • Method for producing N-vinyl pyrrolidone from lactone-free pyrrolidone
    BASF 2229357*

  • Indoles and their therapeutic use
    Pulmagen Therapeutics (Asthma) 2229358*

  • Process for the manufacture of an indoline derivative
    Boehringer Ingelheim International 2229359*

  • Indolinone derivatives and process for their manufacture
    Boehringer Ingelheim International 2229360*

  • Tetrahydroindoles having sphingosine-1-phosphate receptor activity
    Allergan 2229361*

  • Piperazines as anti-obesity agents
    AstraZeneca 2229362*

  • Renin inhibitors
    Merck Frosst Canada 2229363*

  • Dibenzoazepine and dibenzooxazepine TRPA1 agonists
    Janssen Pharmaceutica 2229364*

  • Method for improving the hydrolysis stability of ionic liquids
    BASF 2229365*

  • Method for reprocessing mixtures containing imidazolium salts
    BASF 2229366*

See more

You may also like

Digital

Pharma cybersecurity challenges: a holistic prescription

Read more
The pharmaceutical sector remains a prime target for cyberattacks. As an industry built on innovation, with extensive investments in research and development (R&D), intellectual property (IP) and patient information, it bridges the divide between business and healthcare, becoming a hotspot in the health data threat landscape

Trending Articles

  1. Pfizer wins battle over Viagra trademark Energy drinks brand Viaguara cannot be registered as an EU trademark
  2. Patent applications published 7 July 2010 Selected patent applications from the weekly European Patents Bulletin
  3. Genmab says GSK has settled patent case with Genentech Concerning two US patents for ofatumumbab
  4. Boehringer Ingelheim suffers Spiriva patent blow in India Indian patent office has revoked a patent granted for tiotropium bromide monohydrate under the Spiriva brand, paving the way for Cipla to continue selling its generic version in the Indian market
  5. Phillips-Medisize acquires mini-tablet dispenser patent The US company has acquired exclusive ownership of the patent from a global pharmaceutical company and expects to make the product available by early 2020

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Digital

Pharma cybersecurity challenges: a holistic prescription

The pharmaceutical sector remains a prime target for cyberattacks. As an industry built on innovation, with extensive investments in research and development (R&D), intellectual property (IP) and patient information, it bridges the divide between business and healthcare, becoming a hotspot in the health data threat landscape
Regulatory

Pharmaseal reaches milestone in crowdfunding campaign

The company was first founded in 2016
Patient Experience

Ilya Pharma awarded engineered lactic acid bacterial strain patent

The patent covers the use of engineered lactic acid bacterial strains for all human and animal wounds, not just skin
Pharmaceutical

A card in the competition for COVID-19 drug supply

The patent system has come under pressure both politically and, more recently, as pharma companies scale-up their operations to make large amounts of drugs available to treat COVID-19, reports Paul England, Senior Professional Support Lawyer at Taylor Wessing
Ingredients

Sigrid Therapeutics obtains US patent for silica-based biomaterial SiPore15 for the treatment and prevention of obesity

Mesoporous silica particles (MSP) are a type of ingestible synthetic amorphous silica particles that can be produced with a large surface area and a range of pore sizes
Ingredients

VistaGen and Nuformix agree to develop cocrystalline forms of AV-101

The drug for treatment of multiple CNS conditions will be reformed into a novel patentable form to potentially improve delivery and give more intellectual property protection
Digital

Documentation complexity at crisis point?

Do we focus too much on the paperwork, to the detriment of product and patients? Has documentation become so complex it’s become a dangerous distraction and your biggest risk? by Martin Lush
Subscribe now